31st Pharmacovigilance 2023: Catalyzing Pharmacovigilance, Drug Safety and Risk Management.

Share this

31st Pharmacovigilance 2023: Catalyzing Pharmacovigilance, Drug Safety and Risk Management.

Virtue Insight is glad to invite you to attend the 31st Pharmacovigilance 2023 which is happening on 01-02 February 2023 at Radisson RED London Heathrow, UK. The focus will be on the latest developments in pharmacovigilance, drug safety & risk management.

With the increasing number of diseases and the non-medical use of prescription drugs, the incidence of drug abuse has increased enormously in recent years. With reference to this, drug safety and pharmacovigilance have emerged as dynamic clinical and scientific disciplines to provide adequate information and ensure health safety through the joint interaction of doctors and patients in choosing appropriate treatment methods and drugs. Through this conference participants will have the opportunity to engage with industry experts, enabling them to discuss advancements, obstacles encountered, and groundbreaking innovations within the pharmaceutical realm.

Registration link: https://virtueinsight.com/event/pharmacovigilance/

PLUS! Discount code for PharmaShots subscribers: VIPV_PS

 The key sponsors for the event are:

Gold Sponsor – Pharsafer

Silver Sponsor - Qinecsa Solutions, CLINEXEL Life Sciences

Bronze Sponsor - Quanticate, Brookwood Global

The key speakers for the event will be:

- KHAUDEJA BANO, Vice President, Combination Product Quality, Amgen

- SIDDHARTH CHACHAD, Executive Vice President & Head - Global Clinical Management, Dr. Reddy’s Laboratories

- JOHN SOLOMON, Head of Pharmacovigilance - UK & Ireland, Sanofi

- MICHAEL BEAN, Senior Director, Regulatory Compliance R&D, Johnson & Johnson

- SUMIT MUNJAL, Vice President, Global Patient Safety Evaluation, Takeda Pharmaceuticals

- YVONNE NANCIU, Country Head Pharmacovigilance, Bayer

- ADI MEISTER, PV Sr. Manager, Teva

- ROBERT MASSOUH, Director - Risk Management Product Lead, Pfizer

- HUMAIRA QURESHI, CEO, Qinecsa Solutions

- RISHI CHOPRA, Global Head of Pharmacovigilance Regions, CSL Behring

- PAV RISHIRAJ, Director – Pharmacovigilance & ABPI PV Expert Chair, Ipsen

- TARAK THAKKER, Director, Safety Systems, BeiGene (USA)

- ELIAN KHAZNEH, Head of Global Patient Safety Benefit Risk Strategy & Mgmt, Merck Healthcare

- FABIO DE GREGORIO, Vice President, Head of Drug Safety Europe, Shionogi Europe

- RAJ BHOGAL, Senior Director, R&D Audits & Inspections, Jazz Pharmaceuticals

- FATIMA YOUSEF GHETHAN, Quality Culture & Implementation Manager, Executive Administration of Quality & Patient Safety, Makkah Healthcare Cluster (UAE)

- LUIZ LIMA, Senior Medical Director, Ipsen

- ANNA HELENA STAHL, Senior Director, Pharmacovigilance; EU QPPV, Bavarian Nordic

- ALINA TUDOR, Senior Director, Pharmacovigilance, Kyowa Kirin International

- ROHAN MANE, Director, Safety Risk Management Centre of Excellence, Pfizer

- ANDREA OLIVA, Head of Pharmacovigilance, Viatris

- DNYANESHWAR SANAP, EU/UK QPPV, Head Regional PV and Global Compliance & Training, Glenmark Pharmaceuticals

- VALENTINA MANCINI, Director PV, EU QPPV, Shionogi Europe

- TEA BABIC, Director, Head of Global PV Audits and Inspections, Deputy Head PV Compliance, Teva


- DEEPA ARORA, Chief Executive Officer, CLINEXEL Life Sciences

- MIJAL CHAVDA, Global Head of GxP Inspection & GVP Quality, Kyowa Kirin

- ALESSANDRO VAGHEGGINI, Associate Principal Biostatistician, BARDS-CSS, MSD Merck Sharp & Dohme

- LUDIVINE DOUARIN, Benefit-Risk Expert, Sanofi

- TOMMASO VENTURI, Corporate Pharmacovigilance Risk Assessment Specialist, ITALFARMACO

- EMANUEL LOHRMANN, Lead Safety Physician, Otsuka Pharmaceutical

- KAPIL BHUTADA, Director, Pharmacovigilance Compliance and Training, Medicago

- KETAN MARULKAR, Senior Pharmacovigilance Officer, Chanelle Pharma

- ATTILA OLAH, Head of Global Patient Safety, Gedeon Richter

- DANIELA DI COSMO, Senior PV Manager, Global PV, Ferring Pharmaceuticals

- DARIUS-JEAN NAMDJOU, Head of Regulatory Affairs & Pharmacovigilance, Immunic Therapeutics

- GAURI UTTURKAR, Patient Safety Physician, UCB

- OLEKSANDR KARPENKO, Director, Olexacon

- MARIA BEATRICE PANICO, Principal Consultant, Scendea

- MARINA SUVAKOV, Global Head Product Safety Surveillance, Philip Morris International

- DIMITRIS ZAMPATIS, Global Program Safety Lead, Sandoz

- ALEXANDER ROUSSANOV, International Partner, Life Sciences and Privacy, Arnold & Porter

The key themes discussed will be:

- Future of pharmacovigilance - Making medicines safe in an increasingly complex world

- Market analysis – Pharmacovigilance in 2023 - future horizons and efficiencies

- Refining the PV environment - Rising back from the pandemic

- Rethinking the relationship between Sponsor, Site, CRO & Patients – Working together

- Why does pharmacovigilance sometimes fail and where could the fault lie?

- Outsourcing in Pharmacovigilance- Best Practices, Challenges, and key consideration

- Documentation (RMPs, PSURs, PADERs, PBRERs)

- Quality, Safety & Signal Detection – Overall approach

- From policy to practice: Prioritising Patients

- Developmental Risk management plans in Pharmacovigilance

- Impact of technology - Automation in Pharmacovigilance: A Closer look at use cases

- Plan, develop, and implement the PV Audit strategy plan

- Medical devices – Increasing safety perspective

- Case studies from various countries on the PV frameworks around the world

- Prioritising Patients - Reshaping patient safety

- Brexit Implications for the Pharmaceutical (pharmacovigilance) Industry

- New Technologies in Pharmacovigilance (AI/ Machine Learning, IoT)

- Regulatory - EU and UK Regulations & Guidelines in Pharmacovigilance

- Be part of a major networking opportunity

In this context, we cordially invite you to register for the event.


Early Bird Discount Price (Valid till 24 Dec 2022):

1 Delegate - £899 +VAT

3 Delegates for the price of 2 - £1798 +VAT

STANDARD PRICE (Valid from 25 Dec 2022):

1 Delegate @ £1299 + VAT

Group Discount @ £2598 + VAT (3 Delegates for the price of 2)

We have sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit and create brand awareness.  Here you can have dedicated networking time, meet the leading international vendors and expand your knowledge of the latest business models. 

For any details and queries please contact Kavitha at email - kavitha@virtueinsight.co.in or call +44 20 3509 3779

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, and meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies at the high-level conference.

Related Post: Exclusive Coverage: CPHI & PMEC India 2022

Senior Editor

Senior Editor at PharmaShots. She is curious and very passionate about recent updates and developments in the life sciences industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions